[Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].

S Charhon(Inserm), Meunier Pj, A. Valentin-Opran(Inserm), C Edouard, Chapuy Mc, S Rosini
PubMed
December 24, 1983
Cited by 6

Related Papers

RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
|BMJ|1980|585
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
|Journal of Bone and Joint Surgery|2006|447
Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2
|Clinical Orthopaedics and Related Research|2002|290
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia
|Cancer|1983|210